BDX Q1 2026 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$60B

Q1 2026 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$5.3B+1.6% YoY

Gross Profit

$2.3B44.6% margin

Operating Income

$594M11.3% margin

Net Income

$382M7.3% margin

EPS (Diluted)

$1.34

QoQ Revenue Growth

-10.8%

Cash Flow

Operating Cash Flow

$657M

Free Cash Flow

$549M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$54.8B

Total Liabilities

$29.6B

Stockholders' Equity

$25.3B

Cash & Equivalents

$1.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.3B	$5.2B	+1.6%
Gross Profit	$2.3B	$2.2B	+4.9%
Operating Income	$594M	$453M	+31.1%
Net Income	$382M	$303M	+26.1%

Revenue Segments

Life Sciences

$2.5B51%

Medical

$2.4B49%

Geographic Segments

UNITED STATES

$3.2B60%

Non-US

$2.1B40%